Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
This study is being conducted to see if adding GW679769 (casopitant) to ZOFRAN will
 significantly decrease the number of patients who experience nausea and vomiting after
 surgery.
Inclusion criteria:

 -  History of PONV (postoperative nausea and vomiting) and/or motion sickness.

 -  Have not smoked for the last 6 months.

 -  Having certain abdominal, breast, thyroid or shoulder surgery.

 Exclusion criteria:

 -  Pregnant or breastfeeding.

 -  Have certain pre-existing medical conditions or take certain medications.